HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renaud Jardri Selected Research

Hallucinations (Hallucination)

1/2022From hallucinations to synaesthesia: A circular inference account of unimodal and multimodal erroneous percepts in clinical and drug-induced psychosis.
1/2022Decoding Activity in Broca's Area Predicts the Occurrence of Auditory Hallucinations Across Subjects.
12/2021Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.
12/2020Real-Time Functional Magnetic Resonance Imaging Neurofeedback for the Relief of Distressing Auditory-Verbal Hallucinations: Methodological and Empirical Advances.
12/2020Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison.
1/2018Prediction of activation patterns preceding hallucinations in patients with schizophrenia using machine learning with structured sparsity.
1/2018A latent class analysis of psychotic symptoms in the general population.
10/2017fMRI capture of auditory hallucinations: Validation of the two-steps method.
3/2016Effects of Fronto-Temporal Transcranial Direct Current Stimulation on Auditory Verbal Hallucinations and Resting-State Functional Connectivity of the Left Temporo-Parietal Junction in Patients With Schizophrenia.
1/2016Translating Neurocognitive Models of Auditory-Verbal Hallucinations into Therapy: Using Real-time fMRI-Neurofeedback to Treat Voices.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Renaud Jardri Research Topics

Disease

17Hallucinations (Hallucination)
01/2022 - 01/2009
8Schizophrenia (Dementia Praecox)
01/2022 - 01/2008
3Cognitive Dysfunction
01/2022 - 12/2017
2Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 05/2013
2Catatonia
10/2021 - 11/2018
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Neurobehavioral Manifestations
12/2021
1Mood Disorders (Mood Disorder)
06/2019
1Major Depressive Disorder (Major Depressive Disorders)
06/2019
1Seizures (Absence Seizure)
11/2018
1Psychomotor Agitation (Akathisia)
11/2018
1Alcoholism (Alcohol Abuse)
02/2017
1Neonatal Abstinence Syndrome
01/2016
1Inflammation (Inflammations)
06/2013
1Dystonia (Limb Dystonia)
01/2009

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
01/2022 - 01/2009
5Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 01/2009
3Hallucinogens (Psychedelics)IBA
01/2022 - 01/2014
2salicylhydroxamic acid (SHAM)IBA
12/2021 - 03/2016
2Biological ProductsIBA
12/2021 - 10/2021
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2016 - 01/2014
1Aripiprazole (Abilify)FDA Link
01/2022
1Clozapine (Clozaril)FDA LinkGeneric
01/2022
1Dopamine Agonists (Dopamine Agonist)IBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
10/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021
1Rituximab (Mabthera)FDA Link
10/2021
1Antidepressive Agents (Antidepressants)IBA
06/2019
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2019
1Lorazepam (Ativan)FDA LinkGeneric
11/2018
1VigabatrinFDA Link
11/2018
1SolutionsIBA
01/2018
1BaclofenFDA LinkGeneric
02/2017
1nasIBA
01/2016
1gamma-Aminobutyric Acid (GABA)IBA
01/2016
1tianeptine (Stablon)IBA
01/2016
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2014
1Glutamic Acid (Glutamate)FDA Link
01/2014
1Serotonin (5 Hydroxytryptamine)IBA
01/2014
1Dissociative AnestheticsIBA
01/2014
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2013
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
06/2013
1LipidsIBA
06/2013
1Risperidone (Risperdal Consta)FDA LinkGeneric
01/2008

Therapy/Procedure

5Therapeutics
01/2022 - 01/2016
4Transcranial Magnetic Stimulation
06/2019 - 04/2010
3Neurofeedback
12/2020 - 01/2016
2Transcranial Direct Current Stimulation
12/2021 - 03/2016
1Immunotherapy
10/2021
1Plasma Exchange
10/2021
1Bathroom Equipment
11/2018
1Institutionalization (Institutionalized Persons)
12/2017
1Electrodes (Electrode)
03/2016